Breadcrumb

What's New at the RI-MUHC ?

Training physicians to improve blood transfusion safety and pertinence: a successful strategy

Rates in blood transfusions have decreased at the MUHC following the implementation of an educational...

Could a rehabilitation program make a difference in the lives of long COVID sufferers

Researchers are seeking new ways to help the thousands of Canadians living with debilitating long-term effects...

Alveolar macrophages on patrol for respiratory health

In a study published in Nature, RI-MUHC researchers examine how the lung copes with invading microbes

Significant funding to maximize access and drive excellence in clinical trials in Quebec and Canada

RI-MUHC researchers will lead or co-lead multiple projects awarded a total of $55 million from the Canadian Institutes...

MI4 announces redefined scope: How microbes shape human health and disease, from molecules to patients to populations

Five years in, the McGill Interdisciplinary Initiative in Infection and Immunity...

Triple-negative breast cancer: the RI-MUHC enrolls first patients in international Phase 3 clinical trial

The first participants in this large study were recently selected at the Cedars Cancer Centre of the MUHC.

Researchers discover how brain cells may be hardwired for vulnerability to deadly childhood brain tumour

A clearer understanding of how brain tumours originate during brain development is paving the way for improved therapies against pediatric high-grade gliomas, the leading cause of cancer-related deaths in children and young adults.

Happy first anniversary to the Quebec SmartCare Consortium!

Led by the Opal group at the RI-MUHC, the consortium has already made advances in data infrastructure and governance, as well as improving...

$2 million USD to investigate new approaches for prostate cancer treatment

RI-MUHC researcher David P. Labbé and a team of international collaborators will investigate the mechanisms...

Learn more about the RI-MUHC